Search

everythinglearnresearchcommunity

for

Search:↓

A man's breast enlargement from low-dose finasteride for hair loss didn't go away, even with treatment, and might be more common than reported.

Light therapy might help treat hereditary hair loss by improving hair follicle growth in lab cultures.

Genetic risk for PCOS can affect children's growth, metabolism, and development from early life into adulthood.

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.

Hair shaft disorders, often due to genetics or environment, lack specific treatments but can be managed with gentle hair care and may improve with age or topical treatments.

The treatment showed promising hair growth results but needs more research.

Combining SVF cells with PRP may boost hair growth in androgenic alopecia.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Androgens affect hair growth and shedding, with genetic and non-genetic factors influencing baldness.

Pmg-1 and Pmg-2 are new genes important for skin and mammary gland development.

Dromedary camel hair structure and mineral content change with age.

A new gene mutation causes complete androgen insensitivity in a 16-year-old with a female appearance.

A genetic variant in the KRT71 gene may cause loose anagen hair and wooly hair, and symptoms might improve with age.

PCOS is a hereditary disorder that can lead to diabetes and heart disease if not treated early.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Environmental factors and chemicals might affect hormone balance and contribute to common hair loss.

The document concludes that understanding dermal papilla cells is key to improving hair regeneration treatments.

Fetal environments contain various chemicals that may disrupt hormones.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Finasteride reduces Hidradenitis Suppurativa flare-ups in children and teens, but long-term safety is unknown.

Niacin derivatives may increase hair fullness in women with hair loss.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

The document concludes that better biomarkers are needed to detect long-term oral testosterone use in athletes.

Women's hair generally gets thinner and less dense starting in their mid-thirties, with hair loss becoming more common as they age due to both genetics and environment.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.